老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

La Jolla Pharmaceutical Company

6.22
0.0000
成交量：- -
成交額：166.46萬
市值：1.55億
市盈率：48.19
高：6.22
開：6.22
低：6.22
收：6.22
資料載入中...
總覽公司新聞公告
2021/12/06

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/04

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/27

重要事件披露

8-K - Current report
2021/05/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/08

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
更多